Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin. [electronic resource]
- Journal of chemotherapy (Florence, Italy) Apr 2016
- 83-8 p. digital
Publication Type: Journal Article
1973-9478
10.1179/1973947815Y.0000000050 doi
Aminoglycosides--pharmacology Anti-Bacterial Agents--pharmacology Europe Gram-Positive Bacteria--drug effects Gram-Positive Bacterial Infections--microbiology Hospitals Humans Israel Lipoglycopeptides Microbial Sensitivity Tests--methods Russia